June 6, 2017
Amicus Therapeutics Receives Rare Pediatric Disease Designation for SD-101 for Patients with Epidermolysis Bullosa
Read More
June 11, 2015
Global Genes to Host Fourth Annual Tribute to Champions of Hope Gala and Patient Advocacy Summit
Read More
October 23, 2014
New RARE Toolkit “Searching For Answers: Contacting Biopharmaceutical Companies Effectively”
Read More
August 22, 2014
Amicus Therapeutics Announces Positive Phase 3 Data from Fabry Monotherapy Study
Read More
September 25, 2013
Rare Disease Congressional Caucus Briefing Co-Hosted by Shire and RDLA
Read More
X